-
Product Insights
Sedibeng Iron Ore Project
The Sedibeng Iron Ore Project is a iron ore mine in South Africa. It is currently in operation. Empower your strategies with our Sedibeng Iron Ore Project report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance....
-
Product Insights
Siroka Draga Wind Farm
Siroka Draga Wind Farm is an Onshore Wind project located in Canton 10, Bosnia and Herzegovina. The project is owned and being developed by ENPRODE Engineering & Consulting; IMRES SmartGreenergy doo. The project is at the permitting stage. Empower your strategies with our Siroka Draga Wind Farm report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase,...
-
Product Insights
Enprode/ IMRES SmartGreenergy – Siroka Draga Wind Farm 100 MW – Federation of Bosnia and Herzegovina
Equip yourself with the essential tools needed to make informed and profitable decisions with our Enprode/ IMRES SmartGreenergy - Siroka Draga Wind Farm 100 MW - Federation of Bosnia and Herzegovina report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report?...
-
Company Profile
Enliven Therapeutics Inc – Company Profile
Enliven Therapeutics Inc (Enliven Therapeutics), formerly a Imara Inc, is a clinical-stage precision oncology company that discovers and develops small molecule kinase inhibitors. The company product pipeline includes ELVN- 001 and ELVN- 002. Its product treats chronic myeloid leukemia (CML), non-small cell lung cancer (NSCLC) and solid tumors. Enliven Therapeutics pipeline program includes BCR-ABL and HER2 which carries out gene fusion, oncogenic, small molecule inhibitors and HER2 mutations including exon 20 insertion mutations (E20IMs) in non-small cell lung cancer (NSCLC)....
Add to Basket -
Product Insights
Cardiac Valve Repair – Edwards Lifesciences Corp – CARPENTIER-MCCARTHY-ADAMS IMR ETLOGIX
GlobalData, the industry analysis specialist, has released its latest report: Cardiac Valve Repair - Edwards Lifesciences Corp - CARPENTIER-MCCARTHY-ADAMS IMR ETLOGIX. The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches. In addition, the final selling pricing of medical devices is also...
-
Product Insights
Thalassemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Thalassemia is a group of inherited blood disorders that affect the body's ability to produce hemoglobin and red blood cells. Symptoms include fussiness, paleness, frequent infections, failure to thrive, poor appetite, and jaundice. Treatment includes blood transfusions and bone marrow transplants. The Thalassemia Drugs in Development market research report provides an overview of the Thalassemia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Thalassemia, complete with analysis by stage of development, drug target, mechanism of...
-
Product Insights
Nuclear Factor Erythroid 2 Related Factor 2 (HEBP1 or Nuclear Factor Erythroid Derived 2 Like 2 or NFE2L2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Nuclear factor (erythroid-derived 2)-like 2 or Nrf2 is a transcription factor encoded by the NFE2L2 gene. It binds to antioxidant response elements in the promoter regions of target genes. It is important for the coordinated up-regulation of genes in response to oxidative stress. It is involved in the transcriptional activation of genes of the beta-globin cluster by mediating enhancer activity of hypersensitive site 2 of the beta-globin locus control region. The Nuclear Factor Erythroid 2 Related Factor 2 - Drugs...